{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:17:08Z","timestamp":1788380228495,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007929","name":"Institute for Translational Medicine and Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL113252"],"award-info":[{"award-number":["R01HL113252"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61\/R33HL137063"],"award-info":[{"award-number":["R61\/R33HL137063"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HL145435"],"award-info":[{"award-number":["U01HL145435"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F31HL170550"],"award-info":[{"award-number":["F31HL170550"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajt.2026.08.009","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:32:23Z","timestamp":1786750343000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The early posttransplant lung microbiome and IP10\/CXCL10 are associated with chronic lung allograft dysfunction: A prospective study with 5-year follow-up"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7628-1828","authenticated-orcid":false,"given":"Carter","family":"Merenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6451-5121","authenticated-orcid":false,"given":"John E.","family":"McGinniss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9986-2994","authenticated-orcid":false,"given":"Robert","family":"Gallop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0088-3101","authenticated-orcid":false,"given":"Samantha A.","family":"Whiteside","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9035-3181","authenticated-orcid":false,"given":"Krishna","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-3656","authenticated-orcid":false,"given":"Michelle","family":"Oyster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9421-7363","authenticated-orcid":false,"given":"Jevon","family":"Graham-Wooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel","family":"Kalman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2130-7848","authenticated-orcid":false,"given":"Emily","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1105-0129","authenticated-orcid":false,"given":"Edward","family":"Cantu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3695-4637","authenticated-orcid":false,"given":"Joshua M.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4740-4056","authenticated-orcid":false,"given":"Frederic D.","family":"Bushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0519-218X","authenticated-orcid":false,"given":"Jason D.","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0508-3701","authenticated-orcid":false,"given":"Ronald G.","family":"Collman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"157","key":"10.1016\/j.ajt.2026.08.009_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0132-2019","article-title":"Developments in lung transplantation over the past decade","volume":"29","author":"van der Mark","year":"2020","journal-title":"Eur Respir Rev"},{"issue":"9","key":"10.1016\/j.ajt.2026.08.009_bib2","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/TP.0000000000001215","article-title":"Chronic lung allograft dysfunction: a systematic review of mechanisms","volume":"100","author":"Royer","year":"2016","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.ajt.2026.08.009_bib3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.201104-0655OC","article-title":"Topographical continuity of bacterial populations in the healthy human respiratory tract","volume":"184","author":"Charlson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ajt.2026.08.009_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02287-16","article-title":"Bacterial topography of the healthy human lower respiratory tract","volume":"8","author":"Dickson","year":"2017","journal-title":"mBio"},{"issue":"15","key":"10.1016\/j.ajt.2026.08.009_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150473","article-title":"The lung microbiome: progress and promise","volume":"131","author":"Whiteside","year":"2021","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.ajt.2026.08.009_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047305","article-title":"The lung microbiome in moderate and severe chronic obstructive pulmonary disease","volume":"7","author":"Pragman","year":"2012","journal-title":"PLoS ONE"},{"issue":"suppl 1","key":"10.1016\/j.ajt.2026.08.009_bib7","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1513\/AnnalsATS.201306-159MG","article-title":"The cystic fibrosis lung microbiome","volume":"11","author":"Surette","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.ajt.2026.08.009_bib8","doi-asserted-by":"crossref","first-page":"L675","DOI":"10.1152\/ajplung.00258.2020","article-title":"The evolving role of the lung microbiome in pulmonary fibrosis","volume":"319","author":"Lipinski","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"8","key":"10.1016\/j.ajt.2026.08.009_bib9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.healun.2021.04.014","article-title":"The lung microbiome in lung transplantation","volume":"40","author":"McGinniss","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2026.08.009_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/rccm.201204-0693OC","article-title":"Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant","volume":"186","author":"Charlson","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.ajt.2026.08.009_bib11","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/cid\/ciy1047","article-title":"Community-acquired respiratory viruses are a risk factor for chronic lung allograft dysfunction","volume":"69","author":"Peghin","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ajt.2026.08.009_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/cid\/civ871","article-title":"Symptomatic respiratory virus infection and chronic lung allograft dysfunction","volume":"62","author":"Fisher","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ajt.2026.08.009_bib13","article-title":"Risk of lung allograft dysfunction associated with aspergillus infection","volume":"7","author":"Le Pavec","year":"2021","journal-title":"Transplant Direct"},{"issue":"suppl 3","key":"10.1016\/j.ajt.2026.08.009_bib14","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1513\/AnnalsATS.201606-464MG","article-title":"Host-pathogen interactions and chronic lung allograft dysfunction","volume":"14","author":"Belperio","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.ajt.2026.08.009_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S2213-2600(20)30405-7","article-title":"Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study","volume":"9","author":"Combs","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.ajt.2026.08.009_bib16","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1164\/rccm.202110-2413OC","article-title":"Lung allograft microbiome association with gastroesophageal reflux, inflammation, and allograft dysfunction","volume":"206","author":"Schneeberger","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ajt.2026.08.009_bib17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1164\/rccm.201207-1228OC","article-title":"Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation","volume":"187","author":"Gregson","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ajt.2026.08.009_bib18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.201209-1680OC","article-title":"Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome","volume":"187","author":"Willner","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajt.2026.08.009_bib19","article-title":"Systems prediction of chronic lung allograft dysfunction: results and perspectives from the cohort of lung transplantation and systems prediction of chronic lung allograft dysfunction cohorts","volume":"10","author":"Pison","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.ajt.2026.08.009_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TP.0b013e31824db9da","article-title":"Antiinflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection","volume":"94","author":"Vos","year":"2012","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ajt.2026.08.009_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03292-2020","article-title":"Multi-omics profiling predicts allograft function after lung transplantation","volume":"59","author":"Watzenboeck","year":"2022","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ajt.2026.08.009_bib22","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/s41467-021-22344-4","article-title":"A prevalent and culturable microbiota links ecological balance to clinical stability of the human lung after transplantation","volume":"12","author":"Das","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ajt.2026.08.009_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jcf.2025.10.002","article-title":"Lung transplant for CF: Low lung bacterial burden and immune mediators in year one associate with CLAD development","volume":"25","author":"Whiteside","year":"2026","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.ajt.2026.08.009_bib24","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1164\/rccm.202112-2786OC","article-title":"The lung allograft microbiome associates with pepsin, inflammation, and primary graft dysfunction","volume":"206","author":"McGinniss","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ajt.2026.08.009_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment - a consensus report from the Pulmonary council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2026.08.009_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1164\/rccm.201705-0891OC","article-title":"microbial lineages in sarcoidosis. a metagenomic analysis tailored for low-microbial content samples","volume":"197","author":"Clarke","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ajt.2026.08.009_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.ajt.2026.08.009_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/femsec\/fiz045","article-title":"Issues and current standards of controls in microbiome research","volume":"95","author":"Hornung","year":"2019","journal-title":"FEMS Microbiol Ecol"},{"issue":"6","key":"10.1016\/j.ajt.2026.08.009_bib29","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41564-020-0694-0","article-title":"Bacterial colonization reprograms the neonatal gut metabolome","volume":"5","author":"Bittinger","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ajt.2026.08.009_bib30","series-title":"Flexible parametric survival analysis using stata: beyond the cox model","author":"Royston","year":"2011"},{"issue":"15","key":"10.1016\/j.ajt.2026.08.009_bib31","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med."},{"key":"10.1016\/j.ajt.2026.08.009_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41512-018-0026-5","article-title":"The current application of the Royston-Parmar model for prognostic modeling in health research: a scoping review","volume":"2","author":"Ng","year":"2018","journal-title":"Diagn Progn Res"},{"issue":"2","key":"10.1016\/j.ajt.2026.08.009_bib33","first-page":"344","article-title":"Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions","volume":"13","author":"Hinchliffe","year":"2013","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.ajt.2026.08.009_bib34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/1536867X1701700212","article-title":"stpm2cr: A flexible parametric competing risks model using a direct likelihood approach for the cause-specific cumulative incidence function","volume":"17","author":"Mozumder","year":"2017","journal-title":"Stata J"},{"issue":"2","key":"10.1016\/j.ajt.2026.08.009_bib35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1536867X1301300209","article-title":"Extending the flexible parametric survival model for competing risks","volume":"13","author":"Hinchliffe","year":"2013","journal-title":"Stata J"},{"issue":"4","key":"10.1016\/j.ajt.2026.08.009_bib36","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.healun.2025.12.017","article-title":"Lung microbiome quantification and bacterial density as prognostic markers in lung transplantation","volume":"45","author":"Santilli","year":"2026","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.08.009_bib37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41592-025-02923-9","article-title":"MaAsLin 3: refining and extending generalized multivariable linear models for meta-omic association discovery","volume":"23","author":"Nickols","year":"2026","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.ajt.2026.08.009_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1096\/fj.03-0170fje","article-title":"Regulation of TNF-\u03b1- and IFN-\u03bb-induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease","volume":"18","author":"Hardaker","year":"2004","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.ajt.2026.08.009_bib39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2011.03857.x","article-title":"Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant","volume":"12","author":"Neujahr","year":"2012","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2026.08.009_bib40","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/ajt.17108","article-title":"Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction","volume":"22","author":"Shino","year":"2022","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.08.009_bib41","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.healun.2024.11.006","article-title":"Lung allograft dysbiosis associates with immune response and primary graft dysfunction","volume":"44","author":"Nelson","year":"2025","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.08.009_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20085-y","article-title":"Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis","volume":"12","author":"Chacon-Alberty","year":"2022","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ajt.2026.08.009_bib43","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1164\/rccm.201305-0861OC","article-title":"CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction","volume":"188","author":"Shino","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ajt.2026.08.009_bib44","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1600-6143.2009.02645.x","article-title":"Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis","volume":"9","author":"Schaub","year":"2009","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2026.08.009_bib45","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/MOT.0000000000001135","article-title":"Urine CXCL10 as a biomarker in kidney transplantation","volume":"29","author":"Hirt-Minkowski","year":"2024","journal-title":"Curr Opin Organ Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2026.08.009_bib46","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1165\/rcmb.2004-0175OC","article-title":"Inhibition of pulmonary fibrosis by the chemokine IP-10\/CXCL10","volume":"31","author":"Tager","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"10.1016\/j.ajt.2026.08.009_bib47","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.healun.2023.04.005","article-title":"Pseudomonas-dominant microbiome elicits sustained IL-1\u03b2 upregulation in alveolar macrophages from lung transplant recipients","volume":"42","author":"Britton","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ajt.2026.08.009_bib48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2020.03.010","article-title":"Commensal bacteria in the upper respiratory tract regulate susceptibility to infection","volume":"66","author":"Clark","year":"2020","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.ajt.2026.08.009_bib49","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/cid\/ciz968","article-title":"Association between the respiratory microbiome and susceptibility to influenza virus infection","volume":"71","author":"Tsang","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ajt.2026.08.009_bib50","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.healun.2024.01.002","article-title":"Airway pepsinogen A4 identifies lung transplant recipients with microaspiration and predicts chronic lung allograft dysfunction","volume":"43","author":"Ramendra","year":"2024","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2026.08.009_bib51","article-title":"Lung transplant candidates with pretransplant gastroesophageal reflux and antibodies to lung self-antigens have shorter CLAD-free survival after transplant","volume":"8","author":"Razia","year":"2022","journal-title":"Transplant Direct"},{"issue":"7","key":"10.1016\/j.ajt.2026.08.009_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doae020","article-title":"Concurrent abnormal non-acid reflux is associated with additional chronic rejection risk in lung transplant patients with increased acid exposure","volume":"37","author":"Lo","year":"2024","journal-title":"Dis Esophagus"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526027309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526027309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:40:06Z","timestamp":1788378006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613526027309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"alternative-id":["S1600613526027309"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2026.08.009","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The early posttransplant lung microbiome and IP10\/CXCL10 are associated with chronic lung allograft dysfunction: A prospective study with 5-year follow-up","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2026.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}